Schwann cells as a therapeutic target for peripheral neuropathies.
about
Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral NeuropathyNeurotrophin treatment to promote regeneration after traumatic CNS injury.Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma.Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathyTriglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.Bogijetong decoction and its active herbal components protect the peripheral nerve from damage caused by taxol or nerve crush.Drug therapy for chronic idiopathic axonal polyneuropathy.Thymoquinone Alleviates the Experimental Diabetic Peripheral Neuropathy by Modulation of Inflammation.12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.Pro‑neurogenic effects of andrographolide on RSC96 Schwann cells in vitro.Neurotrophins and spinal circuit function.Sugar Composition Analysis of Fuzi Polysaccharides by HPLC-MSn and Their Protective Effects on Schwann Cells Exposed to High Glucose.Pro-neurogenic effect of β-asarone on RSC96 Schwann cells in vitro.Arsenic toxicity and epimutagenecity: the new LINEage.In vivo introduction of transgenes into mouse sciatic nerve cells in situ using viral vectors.Anti-Apoptotic Effect of IGF1 on Schwann Exposed to Hyperglycemia is Mediated by Neuritin, a Novel Neurotrophic Factor.SCY1-Like 1-Binding Protein 1 (SCYL1BP1) Suppressed Sciatic Nerve Regeneration by Enhancing the RhoA Pathway.Scurvy in the 21st century?: Vitamin C deficiency presenting to the neurologist.Preparation, Characterization, and Bioactivity of Chitosan Microspheres Containing Basic Fibroblast Growth Factor
P2860
Q33569693-8B5AA3D5-72D1-485E-A714-7C64A081B14FQ33621822-ED2059B5-994C-4197-B2BC-A894AB5B557CQ34547330-78BD5CC8-BAC0-428C-8A43-CACDDFD777ABQ35028118-A9A6667B-9F9A-4E58-ABC5-1B36AD378F75Q35784340-B460824A-279F-44A8-9945-9D2FD87D3593Q35854702-13648D65-0F08-40C1-BDDC-264C3B432490Q36172067-6367D889-8163-48FB-BC91-88055E33FE3BQ36410068-ED299FB8-4933-449D-84C5-97F0C7142AF7Q37193185-F18A320D-FD6D-4D1C-AC9A-DFC581569069Q37257009-23D3AE48-E824-426E-B925-6BD58B9CA70AQ37297414-5124AF17-B810-4A02-864F-89E14631963EQ38219967-236A7F03-A511-45E3-849E-4FFFFFF6E91AQ38731771-802C3085-E9E7-43BF-88B1-888D0C47E1EAQ38812245-13CE0FE1-C20B-4E24-BC2A-6AAD10FC2E32Q39314163-636A22C9-27F4-4EA5-8091-FF64967BB330Q42222478-A1D769FA-91B2-4FF9-97AA-5818959AC91BQ51267905-C900934F-B530-4DC2-8CFB-E15BB980B971Q54166611-72DF4E5B-1977-4A77-BB4B-BF63BC8E796CQ55150334-3DEF6606-DED2-439B-94CD-4AFDDF810824Q59060479-B21C5449-27BD-41B2-98CB-0FB20C753926
P2860
Schwann cells as a therapeutic target for peripheral neuropathies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Schwann cells as a therapeutic target for peripheral neuropathies.
@en
Schwann cells as a therapeutic target for peripheral neuropathies.
@nl
type
label
Schwann cells as a therapeutic target for peripheral neuropathies.
@en
Schwann cells as a therapeutic target for peripheral neuropathies.
@nl
prefLabel
Schwann cells as a therapeutic target for peripheral neuropathies.
@en
Schwann cells as a therapeutic target for peripheral neuropathies.
@nl
P2860
P1476
Schwann cells as a therapeutic target for peripheral neuropathies.
@en
P2093
Ahmet Höke
Helmar C Lehmann
P2860
P304
P356
10.2174/187152710793237412
P577
2010-12-01T00:00:00Z